FX301

Pacira Pharmaceuticals, Inc · Phase 1 active Small molecule

At a glance

Generic name	FX301
Also known as	funapide
Sponsor	Pacira Pharmaceuticals, Inc
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

FX301 CI brief — competitive landscape report
FX301 updates RSS · CI watch RSS
Pacira Pharmaceuticals, Inc portfolio CI